Expertise in
3
conditions

Sonja Loges

25 Martinistrasse Str, 
Hamburg, HH, DE 
Expertise in
3
conditions
25 Martinistrasse Str, 
Hamburg, HH, DE 

Overview

Sonja Loges practices practicing medicine in Hamburg, Germany.

Ms. Loges is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, EGFR Positive Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), PIK3CA-Related Overgrowth Spectrum, and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 99 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

25 Martinistrasse Str, Hamburg, HH, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase Ib/II Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine or Decitabine in Patients With Acute Myeloid Leukemia or as a Single Agent in Patients With Myelodysplastic Syndrome
A Phase Ib/II Multicenter Open-label Study of BGB324 as a Single Agent and in Combination With Cytarabine or Decitabine in Patients With Acute Myeloid Leukemia or as a Single Agent in Patients With Myelodysplastic Syndrome
Enrollment Status: Completed
Publish Date: December 19, 2024
Intervention Type: Drug
Study Drugs: Bemcentinib, Cytarabine, Decitabine
Study Phase: Phase 1/Phase 2
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
A Two-part, Open-label, Randomized, Phase 2/3 Study of Dinutuximab and Irinotecan Versus Irinotecan for Second Line Treatment of Subjects With Relapsed or Refractory Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: December 09, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
View 1 Less Clinical Trial

99 Total Publications

Embedding equity in Germany's National Lung Cancer Screening roll-out: a call to action.
Embedding equity in Germany's National Lung Cancer Screening roll-out: a call to action.
Journal: The Lancet. Oncology
Published: June 01, 2026

Frequently Asked Questions about Sonja Loges

Is Sonja Loges a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Sonja Loges is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sonja Loges participate in research or clinical trials?

Yes. Sonja Loges has published 99 articles and abstracts on conditions like Lung Cancer. You can view a list of Sonja Loges's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Loges's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile